189 related articles for article (PubMed ID: 1346737)
21. Antiallergic properties of antihistamines.
Negro-Alvarez JM; Funes E; García Cánovas A; Hernández J; García-Sellés FJ; Pagán JA; López-Sánchez JD
Allergol Immunopathol (Madr); 1996; 24(4):177-83. PubMed ID: 8939275
[TBL] [Abstract][Full Text] [Related]
22. Effect of cetirizine, ketotifen and chlorpheniramine on the dynamics of the cutaneous hypersensitivity reaction: a comparative study.
Snyman JR; Sommers DK; Gregorowski MD; Boraine H
Eur J Clin Pharmacol; 1992; 42(4):359-62. PubMed ID: 1355426
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacological and clinical properties of cetirizine hydrochloride].
Uchida M; Nakahara H
Nihon Yakurigaku Zasshi; 2000 Apr; 115(4):229-35. PubMed ID: 10876807
[TBL] [Abstract][Full Text] [Related]
24. Nonsedating H1 antihistamines in chronic urticaria.
Monroe EW
Ann Allergy; 1993 Dec; 71(6):585-91. PubMed ID: 7903515
[TBL] [Abstract][Full Text] [Related]
25. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge.
Charlesworth EN; Massey WA; Kagey-Sobotka A; Norman PS; Lichtenstein LM
J Pharmacol Exp Ther; 1992 Sep; 262(3):964-70. PubMed ID: 1382132
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo.
Fadel R; Herpin-Richard N; Rihoux JP; Henocq E
Clin Allergy; 1987 Jul; 17(4):373-9. PubMed ID: 2887304
[TBL] [Abstract][Full Text] [Related]
27. Compared peripheral H1 inhibiting effects of cetirizine 2 HCl and loratadine.
Rihoux JP; Ghys L; Coulie P
Ann Allergy; 1990 Aug; 65(2):139-42. PubMed ID: 1974399
[TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
Roongapinun S; Wajajamreon S; Fooanant S
J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).
Leprevost C; Capron M; De Vos C; Tomassini M; Capron A
Int Arch Allergy Appl Immunol; 1988; 87(1):9-13. PubMed ID: 2971624
[TBL] [Abstract][Full Text] [Related]
30. Role of antihistamines in allergic disease.
Busse WW
Ann Allergy; 1994 Apr; 72(4):371-5. PubMed ID: 7908779
[TBL] [Abstract][Full Text] [Related]
31. Effects of cetirizine on human eosinophil and neutrophil activation in vitro.
Walsh GM; Moqbel R; Hartnell A; Kay AB
Int Arch Allergy Appl Immunol; 1991; 95(2-3):158-62. PubMed ID: 1682275
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
[TBL] [Abstract][Full Text] [Related]
33. Late-phase cutaneous reactions to platelet activating factor and kallikrein in urticaria.
Juhlin L
Clin Exp Allergy; 1990 Nov; 20 Suppl 4():9-10. PubMed ID: 1980857
[No Abstract] [Full Text] [Related]
34. Platelet-activating factor-induced immediate and late cutaneous reactions.
Rihoux JP; Fadel R; Juhlin L
Int Arch Allergy Appl Immunol; 1991; 94(1-4):299-300. PubMed ID: 1834582
[TBL] [Abstract][Full Text] [Related]
35. Quantitative time course study of the skin response to histamine and the effect of H1 blockers. A 3-week crossover double-blind comparative trial of cetirizine and terfenadine.
Rihoux JP; Van Neste DJ
Dermatologica; 1989; 179(3):129-34. PubMed ID: 2574115
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine.
De Vos C; Joseph M; Leprevost C; Vorng H; Tomassini M; Capron M; Capron A
Int Arch Allergy Appl Immunol; 1989; 88(1-2):212-5. PubMed ID: 2523357
[TBL] [Abstract][Full Text] [Related]
37. Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study.
Nielsen PN; Skov PS; Poulsen LK; Schmelz M; Petersen LJ
Clin Exp Allergy; 2001 Sep; 31(9):1378-84. PubMed ID: 11591187
[TBL] [Abstract][Full Text] [Related]
38. Does reversed-type anaphylaxis in healthy subjects mimic a real allergic reaction?
Henocq E; Rihoux JP
Clin Exp Allergy; 1990 May; 20(3):269-72. PubMed ID: 1973069
[TBL] [Abstract][Full Text] [Related]
39. The effects of a new generation of H1 antihistamines (cetirizine and loratadine) on histamine release and the bronchial response to histamine in atopic patients.
Chyrek-Borowska S; Siergiejko Z; Michalska I
J Investig Allergol Clin Immunol; 1995; 5(2):103-7. PubMed ID: 7655699
[TBL] [Abstract][Full Text] [Related]
40. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil.
Maciel-Guerra H; Penha MÁ; Jorge MFS; Libório RDS; Carrijo ACNDA; Parise-Fortes MR; Miot HA
An Bras Dermatol; 2018 Mar; 93(2):233-237. PubMed ID: 29723372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
